{"text_format":"3","workbook":"xls","n_sheets":2,"sheets":["Table S1","Table S2"],"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Table S1","index":0,"n_rows":15,"n_cols":3,"rows_kept":15,"flags":["formulas_cached_only"]}
["Table S1. Clinical characteristics of men in MIRS cohort (GSE169038)"]
[]
["Clinical feature","Black","White"]
["Number of patients",596,556]
["Gleason Score, n (%)"]
[6,"34 (5.7%)","18 (3.2%)"]
[7,"460 (77.2%)","442 (79.5%)"]
[8,"49 (8.2%)","29 (5.2%)"]
[9,"46 (7.7%)","51 (9.2%)"]
[10,"2 (0.3%)","0 (0%)"]
["NA","5 (0.8%)","16 (2.9%)"]
["Decipher risk group, n (%)"]
["Average","153 (25.7%)","131 (23.6%)"]
["Higher","228 (38.3%)","185 (33.3%)"]
["Lower","215 (36.1%)","240 (43.2%)"]

{"sheet":"Table S2","index":1,"n_rows":22,"n_cols":4,"rows_kept":22,"merged":[[21,0,21,3]],"flags":["formulas_cached_only"]}
["Tabls S2. Clinical characteristics of men in Emory cohort (GSE54460)."]
[]
["Clinical feature","Black","White","P-value"]
["Number of patients",22,46]
["PSA (ng/ml)"]
["Median",6.6,7.1,"0.7931"]
["Interqurtile Range","5.3, 11.2","5.0, 10.8"]
["Pathological stage, n (%)"]
["T1","0 (0%)","2 (4%)"]
["T2","16 (73%)","38 (81%)"]
["T3","6 (27%)","6 (13%)"]
["T4","0 (0%)","1 (2%)"]
["Gleason Score, n (%)"]
["T1","0 (0%)","2 (4%)"]
["T2","16 (73%)","38 (81%)"]
["T3","6 (27%)","6 (13%)"]
["T4","0 (0%)","1 (2%)"]
["Follow-up for men without recurrence (months)"]
["Median","68.0",63.5,"0.9501"]
["Interqurtile Range","26.6, 77.3","20.2, 96.7"]
[]
["1 P-values obtained from Wilcoxon Rank-Sum test"]